145.63
price up icon0.20%   0.4201
 
loading

Finanzdaten der Gilead Sciences Inc-Aktie (GILD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.01%
7,925.00
7,769.00 7,082.00 6,667.00 7,569.00
Cost Of Revenue
3.51%
1,624.00
1,569.00 1,501.00 1,540.00 1,581.00
Gross Profit
1.63%
6,301.00
6,200.00 5,581.00 5,127.00 5,988.00
Operating Expenses
50.26%
4,317.00
2,873.00 3,107.00 2,890.00 3,536.00
Benefits Costs and Expenses
41.64%
5,847.00
4,128.00 4,653.00 5,018.00 5,402.00
Costs And Expenses
33.75%
5,941.00
4,442.00 4,608.00 4,430.00 5,117.00
Operating Income/Loss
40.37%
1,984.00
3,327.00 2,474.00 2,237.00 2,452.00
Nonoperating Income/Loss
38.66%
349.00
569.00 208.00 -328.00 -35.00
Income/Loss From Continuing Operations Before Tax
42.93%
2,078.00
3,641.00 2,429.00 1,649.00 2,167.00
Income Tax Expense/Benefit, Deferred
118.51%
-122.00
659.00 -178.00 -199.00 -379.00
Income Tax Expense/Benefit
117.83%
-105.00
589.00 468.00 334.00 385.00
Income/Loss From Continuing Operations After Tax
28.47%
2,183.00
3,052.00 1,961.00 1,315.00 1,782.00
Net Income/Loss
28.47%
2,183.00
3,052.00 1,960.00 1,315.00 1,783.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.08%
-1.00
1,243.00 1,245.00 1,246.00 -
Diluted Average Shares
100.08%
-1.00
1,254.00 1,255.00 1,259.00 8.00
Basic Earnings Per Share
28.46%
1.76
2.46 1.57 1.06 1.42
Diluted Earnings Per Share
28.40%
1.74
2.43 1.56 1.04 1.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general NVO
$37.96
price down icon 0.11%
$371.90
price up icon 0.95%
drug_manufacturers_general PFE
$26.76
price down icon 0.50%
drug_manufacturers_general MRK
$116.71
price up icon 0.64%
drug_manufacturers_general NVS
$153.81
price down icon 0.31%
Kapitalisierung:     |  Volumen (24h):